In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:
Times and Dates: 1 p.m.-5 p.m., January 14, 2009; 8:30 a.m.-3:30 p.m., January 15, 2009.
Place: CDC, 1825 Century Boulevard, NE., Century Center Building 2400, Room 1042, Atlanta, Georgia 30345.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people.
Purpose: This BSC is charged with providing advice and guidance to the Secretary of Health and Human Services, the Director of CDC, and the Director of CCHP concerning strategies and goals for the programs and research within the National Center on Birth Defects and Developmental Disabilities and the National Center for Chronic Disease Prevention and Health Promotion.
Matters To Be Discussed: The agenda will include an introduction to the federal advisory committee process for new members; an overview of the CDC, CCHP, and the national centers; and a discussion of the secondary review process.
Agenda items are subject to change as priorities dictate.
Providing Oral or Written Comments: It is the policy of the BSC, CCHP to accept written public comments and provide a brief period for oral public comments. Oral Comments: In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes (unless otherwise indicated). Speakers must also submit their comments in writing for inclusion in the meeting's Summary Report. To ensure adequate time is scheduled for public comments, individuals or groups planning to make an oral presentation should, when possible, notify the contact person below at least one week prior to the meeting date. Written Comments: For individuals or groups unable to attend the meeting, the CCHP BSC accepts written comments until the date of the meeting (unless otherwise stated). However, the comments should be received at least one week prior to the meeting date so that the comments may be made available to the BSC for their consideration and public distribution. Written comments, one hard copy with original signature, should be provided to the contact person below. Written comments will be included in the meeting's Summary Report.
Contact Person for Additional Information: Karen Steinberg, PhD, Senior Science Officer, Coordinating Center for Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop E-70, Atlanta, Georgia 30341; telephone (404) 498-6700; fax (404) 498-6880; or via e-mail at Karen.Steinberg@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: December 12, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E8-30486 Filed 12-22-08; 8:45 am]
BILLING CODE 4163-18-P